drugset / Trial / NCT02232776
Efficacy and Safety of Losartan in Children With Ig A Nephropathy
Phase 3
Completed
37 enrolled
Seoul National University Hospital
Ministry of Food and Drug Safety, Korea · collab
NaSingle-groupOpen-labelTreatment
Summary
The investigators hypothesize that using Losartan would help decrease proteinuria in controlling proteinuria in children with immunoglobulin A nephropathy.
Timeline
- Start
- 2014-10
- Primary completion
- 2016-12
- Completion
- 2017-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Losartan | Other / unclassified | 0.7 mg/kg | — |